chr7-103557156-G-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_005045.4(RELN):​c.5618C>T​(p.Thr1873Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0035 in 1,610,538 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 30 hom. )

Consequence

RELN
NM_005045.4 missense

Scores

5
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:14

Conservation

PhyloP100: 6.20
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), RELN. . Gene score misZ 2.2497 (greater than the threshold 3.09). Trascript score misZ 4.2638 (greater than threshold 3.09). GenCC has associacion of gene with ankylosing spondylitis, lissencephaly with cerebellar hypoplasia, Norman-Roberts syndrome, complex neurodevelopmental disorder, autosomal dominant epilepsy with auditory features, familial temporal lobe epilepsy 7.
BP4
Computational evidence support a benign effect (MetaRNN=0.006139159).
BP6
Variant 7-103557156-G-A is Benign according to our data. Variant chr7-103557156-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 167582.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=7, Uncertain_significance=1}. Variant chr7-103557156-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00269 (410/152300) while in subpopulation SAS AF= 0.0193 (93/4818). AF 95% confidence interval is 0.0161. There are 3 homozygotes in gnomad4. There are 216 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RELNNM_005045.4 linkuse as main transcriptc.5618C>T p.Thr1873Ile missense_variant 38/65 ENST00000428762.6 NP_005036.2
RELNNM_173054.3 linkuse as main transcriptc.5618C>T p.Thr1873Ile missense_variant 38/64 NP_774959.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkuse as main transcriptc.5618C>T p.Thr1873Ile missense_variant 38/655 NM_005045.4 ENSP00000392423 P5P78509-1

Frequencies

GnomAD3 genomes
AF:
0.00270
AC:
411
AN:
152182
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00807
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0193
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00328
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.00409
AC:
1026
AN:
250932
Hom.:
9
AF XY:
0.00504
AC XY:
683
AN XY:
135614
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.00835
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.0148
Gnomad FIN exome
AF:
0.000833
Gnomad NFE exome
AF:
0.00353
Gnomad OTH exome
AF:
0.00507
GnomAD4 exome
AF:
0.00359
AC:
5229
AN:
1458238
Hom.:
30
Cov.:
30
AF XY:
0.00412
AC XY:
2989
AN XY:
725766
show subpopulations
Gnomad4 AFR exome
AF:
0.000479
Gnomad4 AMR exome
AF:
0.000962
Gnomad4 ASJ exome
AF:
0.00888
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.0156
Gnomad4 FIN exome
AF:
0.000806
Gnomad4 NFE exome
AF:
0.00293
Gnomad4 OTH exome
AF:
0.00387
GnomAD4 genome
AF:
0.00269
AC:
410
AN:
152300
Hom.:
3
Cov.:
32
AF XY:
0.00290
AC XY:
216
AN XY:
74478
show subpopulations
Gnomad4 AFR
AF:
0.000577
Gnomad4 AMR
AF:
0.000915
Gnomad4 ASJ
AF:
0.00807
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.0193
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00328
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00396
Hom.:
5
Bravo
AF:
0.00235
TwinsUK
AF:
0.00270
AC:
10
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00435
AC:
528
Asia WGS
AF:
0.00346
AC:
12
AN:
3478
EpiCase
AF:
0.00442
EpiControl
AF:
0.00516

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:14
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:7
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024RELN: BS1, BS2 -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 01, 2017- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJan 25, 2018- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Norman-Roberts syndrome Uncertain:1Benign:2
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Uncertain significance, criteria provided, single submitterresearchLupski Lab, Baylor-Hopkins CMG, Baylor College of MedicineSep 01, 2017this variant was indentified in an individual with malformations of cortical development -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 28, 2015- -
Benign, criteria provided, single submitterclinical testingGeneDxDec 13, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoJul 15, 2019- -
Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 30, 2024- -
RELN-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 17, 2022This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.057
T;.;.
Eigen
Benign
0.11
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.87
D;D;D
MetaRNN
Benign
0.0061
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.67
N;N;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.064
Sift
Benign
0.41
T;T;T
Sift4G
Benign
0.092
T;T;T
Polyphen
0.0010
B;B;.
Vest4
0.30
MVP
0.15
MPC
0.19
ClinPred
0.015
T
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41275239; hg19: chr7-103197603; API